Рет қаралды 38,514
There are several clinical trials and research initiatives in Japan focused on drugs and therapies aimed at rejuvenating mitochondria. One notable example is the approval of Imeglimin, a first-in-class mitochondria-targeted reagent for type 2 diabetes, by a French biopharmaceutical company, Poxel SA. This drug has been approved for marketing in Japan as of 2021 and has shown favorable safety and tolerability[2]. Imeglimin targets mitochondrial function, which is crucial for its therapeutic effects in diabetes management, indirectly contributing to mitochondrial health.
Additionally, Japan is involved in various other clinical trials and research projects that explore mitochondrial rejuvenation through different mechanisms and diseases. For instance, the clinical trial registry and research initiatives often include studies on mitochondrial diseases and therapies that could potentially rejuvenate mitochondrial function. However, specific ongoing trials directly targeting mitochondrial rejuvenation in Japan were not detailed in the provided search results.
For a comprehensive understanding of all current mitochondrial rejuvenation drug trials in Japan, one would typically refer to databases like ClinicalTrials.gov or research publications from relevant Japanese research institutions and pharmaceutical companies. These sources would provide detailed information on the scope, stage, and findings of such trials.
Citations:
[1] www.ncbi.nlm.nih.gov/pmc/arti...
[2] www.ncbi.nlm.nih.gov/pmc/arti...
[3] www.nature.com/articles/s4141...
[4] pubmed.ncbi.nlm.nih.gov/33473...
[5] classic.clinicaltrials.gov/Pr...
[6] pubmed.ncbi.nlm.nih.gov/30917...
[7] pubmed.ncbi.nlm.nih.gov/36320...
[8] www.astellas.com/en/stories/m...
[9] classic.clinicaltrials.gov/ct...
[10] classic.clinicaltrials.gov/Pr...
[11] pubmed.ncbi.nlm.nih.gov/30348...
[12] classic.clinicaltrials.gov/Pr...
[13] www.mitomoonshot.med.tohoku.a...
[14] pubmed.ncbi.nlm.nih.gov/26850...
[15] classic.clinicaltrials.gov/Pr...
[16] www.sciencedirect.com/science...
[17] classic.clinicaltrials.gov/ct...
[18] onlinelibrary.wiley.com/doi/f...
[19] classic.clinicaltrials.gov/ct...
[20] www.raddarj.org/en/registry/a...